Wakamoto Pharmaceutical Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Mar '12 Mar 31, 2012	Mar '11 Mar 31, 2011	Mar '10 Mar 31, 2010	Mar '09 Mar 31, 2009	Mar '08 Mar 31, 2008
Revenue	9,432	9,669	9,777	10,080	10,169
Revenue Growth (YoY)	-2.45%	-1.10%	-3.01%	-0.87%	-1.54%
Cost of Revenue	4,352	4,493	4,097	3,853	3,547
Gross Profit	5,080	5,176	5,680	6,227	6,622
Selling, General & Admin	4,744	4,884	4,799	4,969	4,985
Research & Development	792	997	874.97	1,005	990.03
Other Operating Expenses	-	-	-3	-1	-12
Operating Expenses	5,580	5,932	5,703	6,023	6,012
Operating Income	-500	-756	-22.89	203.52	610.25
Interest Expense	-28	-27	-19.05	-	-
Interest & Investment Income	34	33	34.66	57.26	33.83
Other Non Operating Income (Expenses)	258	191	176.47	342.84	263.55
EBT Excluding Unusual Items	-236	-559	169.2	603.63	907.63
Merger & Restructuring Charges	-	-	-38	-	-
Gain (Loss) on Sale of Investments	-24	-34	-3.32	-	-
Gain (Loss) on Sale of Assets	125	-9	-	-	-
Asset Writedown	-13	-24	-9.81	-9.41	-14.44
Other Unusual Items	20	-	-	13.16	-175.94
Pretax Income	-128	-626	141	607.37	717.26
Income Tax Expense	94	-201	92.48	256.01	310.37
Net Income	-222	-425	48.52	351.36	406.89
Net Income to Common	-222	-425	48.52	351.36	406.89
Net Income Growth	-	-	-86.19%	-13.65%	-14.72%
Shares Outstanding (Basic)	35	35	34	34	34
Shares Outstanding (Diluted)	35	35	34	34	34
Shares Change (YoY)	0.59%	0.53%	-0.11%	1.62%	4.30%
EPS (Basic)	-6.38	-12.29	1.41	10.20	12.00
EPS (Diluted)	-6.38	-12.29	1.41	10.20	12.00
EPS Growth	-	-	-86.18%	-15.02%	-18.23%
Free Cash Flow	198	-121	-2,120	-1,001	248.84
Free Cash Flow Per Share	5.69	-3.50	-61.62	-29.07	7.34
Dividend Per Share	-	-	5.000	5.000	5.000
Gross Margin	53.86%	53.53%	58.10%	61.77%	65.12%
Operating Margin	-5.30%	-7.82%	-0.23%	2.02%	6.00%
Profit Margin	-2.35%	-4.40%	0.50%	3.49%	4.00%
Free Cash Flow Margin	2.10%	-1.25%	-21.69%	-9.93%	2.45%
EBITDA	508	448	697.21	756.93	1,123
EBITDA Margin	5.39%	4.63%	7.13%	7.51%	11.04%
D&A For EBITDA	1,008	1,204	720.1	553.41	512.27
EBIT	-500	-756	-22.89	203.52	610.25
EBIT Margin	-5.30%	-7.82%	-0.23%	2.02%	6.00%
Effective Tax Rate	-	-	65.59%	42.15%	43.27%
Advertising Expenses	1,179	1,095	1,201	1,277	392.81

Source: S&P Global Market Intelligence. Standard template. Financial Sources.